Correspondence 0001104659-25-004562 from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: Jan. 17, 2025 · CIK: 0001130598 · Accession: 0001104659-25-004562
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284285
Letter
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940
(267) 759-3680
January 17, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Re: Traws Pharma, Inc.
Registration Statement on Form S-3
Filed January 15, 2025
File No. 333-284285
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Traws Pharma, Inc., a Delaware corporation (the “Registrant”), hereby respectfully requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284285) to become effective on Wednesday, January 22, 2025, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration. Please contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Very Truly Yours,
Traws Pharma, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940
(267) 759-3680
January 17, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Re:
Traws Pharma, Inc.
Registration Statement on Form S-3
Filed January 15, 2025
File No. 333-284285
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentleman:
Pursuant to Rule 461
under the Securities Act of 1933, as amended (the “Securities Act”), Traws Pharma, Inc., a Delaware corporation (the
“Registrant”), hereby respectfully requests that the United States Securities and Exchange Commission (the “Commission”)
take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284285) to become effective
on Wednesday, January 22, 2025, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands
that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the
federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes
its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration.
Please contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this
request for acceleration has been granted.
Very Truly Yours,
Traws Pharma, Inc.
By:
/s/ Werner Cautreels
Name: Werner Cautreels
Title: Chief Executive Officer